Antibiotic-Resistant ‘ Superbugs ’ A Growing Health Crisis, New Report Finds

By Elizabeth Cohen and Nadia Kounang, CNN (CNN) — Every 15 minutes, someone in the United States dies of a superbug that has learned to outsmart even our most sophisticated antibiotics, according to a new report from the US Centers for Disease Control and Prevention. That’s about 35,000 deaths each year from drug-resistant infections, according to the landmark report. The report places five drug-resistant superbugs on the CDC’s “urgent threat” list — two more germs than were on the CDC’s list in 2013, the last time the agency issued a report on antibiotic resistance. Genetic research shows germs have become especially adept at teaching each other how to outwit antibiotics. “Some miracle drugs no longer perform miracles,” according to the report. The report also notes that while superbug infections in hospitals are down, some infections caught elsewhere — anywhere in the community — have increased. “This is a problem that ultimately affects all of us,” said Michael Craig, a CDC senior adviser on antibiotic resistance. “It literally has the potential to affect every person on the planet.” Anyone can catch a superbug anywhere While superbugs typically attack frail, elderly people, anyone can contract a superbug. Peggy Lillis was a healthy, vibrant 56-year-old teacher in Brooklyn, who woke up one morning 10 years ago with severe diarrhea. “Being a kindergarten teacher, s...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News Syndicated CBSN Boston Antibiotics CNN Source Type: news

Related Links:

Conclusion:Despite the evidence that obesity can worsen MS prognosis, and the high prevalence of overweight/obesity, case participants were no more likely to adopt a specific diet than control participants. Improved nutrition education may help people with MS make healthy dietary changes for nutrition or weight loss purposes.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
In recent years, rapid advances in scientific discovery have ushered in a new era of medicine, transforming our ability to treat, and in some cases cure, some of the most challenging diseases, includingcancer,rarediseases andautoimmune conditions. These advancements are due to the productivity of the United States ’ biomedical research ecosystem, which is sustained by apolicy framework that is designed to support and advance America ’s leadership in the innovation of new medicines. Central to the success of this ecosystem is the leadership that comes from America’s biopharmaceutical research companies.
Source: The Catalyst - Category: Pharmaceuticals Tags: Research and Development Pelosi Plan & D Focus Source Type: news
This study provides a promising strategy to develop hybrid nanocomposite with enhanced antibacterial efficacy and also opens a new way for the establishment of efficient therapeutic systems with reduced administration frequency as substitute of antibiotics to treat otitis media.Graphical abstract
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research
Publication date: Available online 9 December 2019Source: International Journal of PharmaceuticsAuthor(s): Mohammed Salih, Calvin A. Omolo, Nikhil Agrawal, Pavan Walvekar, Ayman Y. Waddad, Chunderika Mocktar, Charlotte Ramdhin, Thirumala GovenderAbstractThe global threat of antimicrobial resistant strains calls for innovative strategies to utilize nano drug delivery systems to enhance the delivery of antibiotics, thus reducing the development of resistance. Supramolecular amphiphiles that can self-assemble into nanostructures are one such nano delivery system, that are showing potential for effective drug delivery. The aim...
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research
Conditions:   Cardiotoxicity;   Aluminum Phosphid Poisoning Intervention:   Diagnostic Test: serum tropinin, serum CKmb Sponsor:   Assiut University Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Funding Opportunity PAR-20-072 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites submission of investigator-initiated Program Project (P01) applications. The proposed programs may address scientific areas relevant to the NIAID mission including the biology, pathogenesis, and host response to microbes, including HIV; the mechanisms of normal immune function system development and function; and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding
A new study by scientists from The Nature Conservancy (TNC), the University of Bristol and flood analytics company Fathom, seeks to answer an important question related to flooding in the United States – pay now to protect undeveloped areas that are likely to flood in the future or allow developments to go ahead and pay for damage when it occurs.
Source: University of Bristol news - Category: Universities & Medical Training Tags: Research; Faculty of Science, Faculty of Science, School of Geographical Sciences; Press Release Source Type: news
Publication date: Available online 9 December 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Jörg Kleine-Tebbe, Claudia Mailänder
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: Available online 9 December 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Marta Vazquez-Ortiz, Laura Argiz, Adrianna Machinena, Luis Echeverria, Cristina Blasco, Ana Prieto, Sonsoles Infante, Leticia Vila, Emilio Garcia, Purificación Gonzalez-Delgado, Sonia Vazquez-Cortes, Simona Barni, Frederico Martinon-Torres, BIO-FPIES study network
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: Available online 9 December 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Yumiko Miyaji, Limin Yang, Kiwako Yamamoto-Hanada, Masami Narita, Hirohisa Saito, Yukihiro Ohya
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
More News: Acinetobacter | Allergy | Allergy & Immunology | Antibiotic Therapy | Candida | Centers for Disease Control and Prevention (CDC) | Children | Clindamycin | Contracts | Dentistry | Education | Electronic Medical Records (EMR) | Emergency Medicine | Genetics | Health | Health Management | Hospitals | Infectious Diseases | Intensive Care | International Medicine & Public Health | Learning | Nurses | Nursing | Poisoning | Septic Shock | Sports Medicine | STDs | Superbugs | Teachers | Teaching | Universities & Medical Training | Urology & Nephrology | USA Health